Jung‐Hwa Oh
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- Pluripotent Stem Cells Research
- RNA modifications and cancer
- Cancer-related gene regulation
Papers in
-
- Molecular Biology Techniques and Applications 6
- Pluripotent Stem Cells Research 5
- Metabolomics and Mass Spectrometry Studies 4
- Cancer-related gene regulation 4
- Pharmacology 10
- Drug-Induced Hepatotoxicity and Protection 6
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Seokjoo Yoon (37 shared papers)Mi‐Young Son (11 shared papers)Cho‐Rok Jung (10 shared papers)Janghwan Kim (8 shared papers)Jeong‐Min Kim (6 shared papers)Nam-Soon Kim (9 shared papers)Han‐Jin Park (16 shared papers)Mi‐Sun Choi (14 shared papers)
- Journals
- Toxicology Letters (5 papers)Toxicology and Applied Pharmacology (4 papers)Toxicological Research (3 papers)BioChip Journal (3 papers)BMC Genomics (2 papers)
- Partner nations
- South KoreaUnited StatesVietnam
In The Last Decade
Jung‐Hwa Oh
68 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 204
- Molecular Biology 786
- Developmental Neuroscience 39
- Oncology 201
- Health, Toxicology and Mutagenesis 109
Countries citing papers authored by Jung‐Hwa Oh
This map shows the geographic impact of Jung‐Hwa Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Hwa Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Hwa Oh more than expected).
Fields of papers citing papers by Jung‐Hwa Oh
This network shows the impact of papers produced by Jung‐Hwa Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Hwa Oh. The network helps show where Jung‐Hwa Oh may publish in the future.
Co-authors
The 25 scholars most cited alongside Jung‐Hwa Oh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 158 | |
| 2 | 2017 | 139 | |
| 3 | 2018 | 97 | |
| 4 | 2006 | 77 | |
| 5 | 2017 | 68 | |
| 6 | 2015 | 59 | |
| 7 | 2013 | 57 | |
| 8 | 2019 | 55 | |
| 9 | 2017 | 54 | |
| 10 | 2010 | 47 | |
| 11 | 2011 | 42 | |
| 12 | 2006 | 40 | |
| 13 | 2017 | 30 | |
| 14 | 2018 | 30 | |
| 15 | 2006 | 28 | |
| 16 | 2020 | 27 | |
| 17 | 2009 | 27 | |
| 18 | 2004 | 26 | |
| 19 | 2017 | 26 | |
| 20 | 2005 | 22 |
About Jung‐Hwa Oh
Jung‐Hwa Oh is a scholar working on Molecular Biology, Pharmacology, Health, Toxicology and Mutagenesis, Oncology and Genetics, having authored 70 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (6 papers), Molecular Biology Techniques and Applications (6 papers), Pluripotent Stem Cells Research (5 papers), Effects and risks of endocrine disrupting chemicals (5 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Cancer Research (204 citations), Molecular Biology (786 citations), Developmental Neuroscience (39 citations), Oncology (201 citations) and Health, Toxicology and Mutagenesis (109 citations). Jung‐Hwa Oh has collaborated with scholars based in South Korea, United States and Vietnam. Frequent co-authors include Seokjoo Yoon, Mi‐Young Son, Cho‐Rok Jung, Janghwan Kim, Jeong‐Min Kim, Nam-Soon Kim, Han‐Jin Park, Mi‐Sun Choi, Hyun‐Soo Cho and Yong‐Sung Kim. Their work appears in journals such as Toxicology Letters, Toxicology and Applied Pharmacology, Toxicological Research, BioChip Journal and BMC Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.